<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20221002056077N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2022-11-12</date_registration>
      <primary_sponsor>Shahid Beheshti University of Medical Sciences</primary_sponsor>
      <public_title>Comparison of the effect of hip- and ankle- focused training programs on biomechanical risk factors of anterior cruciate ligament injury in female basketball players: Based on the Regional Interdependence Model</public_title>
      <acronym></acronym>
      <scientific_title>Comparison of the effect of hip- and ankle- focused training programs on biomechanical risk factors of anterior cruciate ligament injury in female basketball players</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2022-06-29</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>36</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/66125</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Prevention, Randomization description: Simple randomization
instrument: Packet
In this method, the researcher gives a special number to each  teams. And there are those numbers in the selected envelopes. Therefore, she will have numbered envelopes as many as the number of teams. Then he pours them into a bag or container and stirs them. Then she takes out them one by one and writes down their numbers. And the first to third teams are randomly assigned to the control and intervention groups, Blinding description: The participants, including two experimental groups and a control group, as well as the data analyst, have been blinded. The groups and the data analyst are blinded in a way that they do not know which group they belong to.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Cruciate knee ligament injury.</hc_freetext>
      <i_freetext>Intervention 1: First intervention group: The first intervention group will be given eight weeks of hip strengthening exercises along with PEP exercise program for three sessions a week for eight weeks. These exercises are performed in the warm-up section of the players' daily exercises and last for twenty minutes. In the exercises, the mini-loop band of Traband brand with medium resistance is used. Intervention 2: Second intervention group: The second intervention group will be given eight weeks of ankle strengthening exercises along with PEP exercise program for three sessions a week for eight weeks. These exercises are performed in the warm-up section of the players' daily exercises and last for twenty minutes. In the exercises, the mini-loop band of Traband brand with medium resistance is used. Intervention 3: Control group:  The control group will be given eight weeks of PEP exercise program for three sessions a week for eight weeks. These exercises are performed in the warm-up section of the players' daily exercises and last for twenty minutes. In the exercises, the mini-loop band of Traband brand with medium resistance is used.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
Movement analysis

When:
After result edition

To whom:
Acadamics

Conditions:
Studious

Where to obtain:
nushin.azad@gmail.com

How to obtain:
Send request with an email and we check and send it in 15 days

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Mostafa Zareii</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Daneshjou Blvd, District 1, Tehran, Tehran Province</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1983969411</zip>
        <telephone>+98 21 29901</telephone>
        <email>M_zareei@sbu.ac.ir</email>
        <affiliation>Shahid Beheshti University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Mostafa Zarei</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Daneshjou Blvd, District 1, Tehran, Tehran Province</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1983969411</zip>
        <telephone>+98 21 29910</telephone>
        <email>M_zareei@sbu.ac.ir</email>
        <affiliation>Shahid Beheshti University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>A member of one of youth basketball league teams of Tehran province
The age range of the players should be between 14 and 18 years
Have an average of 3 training sessions per week
Players must be matured
No history of knee ligament tears
No significant abnormalities in lower limbs</inclusion_criteria>
      <agemin>14 years</agemin>
      <agemax>18 years</agemax>
      <gender>Female</gender>
      <exclusion_criteria>Not to exercise 3 sessions a week regularly
Not to follow training protocols regularly
Not to participate in the post-test
Using any other systematic injury prevention exercise program</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>M36</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Systemic disorders of connective tissue in diseases classified elsewhere</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Prevention</i_code>
      <i_code>Prevention</i_code>
      <i_code>Prevention</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>First intervention group: The first intervention group will be given eight weeks of hip strengthening exercises along with PEP exercise program for three sessions a week for eight weeks. These exercises are performed in the warm-up section of the players' daily exercises and last for twenty minutes. In the exercises, the mini-loop band of Traband brand with medium resistance is used.</i_keyword>
      <i_keyword>Second intervention group: The second intervention group will be given eight weeks of ankle strengthening exercises along with PEP exercise program for three sessions a week for eight weeks. These exercises are performed in the warm-up section of the players' daily exercises and last for twenty minutes. In the exercises, the mini-loop band of Traband brand with medium resistance is used.</i_keyword>
      <i_keyword>Control group:  The control group will be given eight weeks of PEP exercise program for three sessions a week for eight weeks. These exercises are performed in the warm-up section of the players' daily exercises and last for twenty minutes. In the exercises, the mini-loop band of Traband brand with medium resistance is used.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>The angle of the ankle. Timepoint: In pre- and post-test. Method of measurement: Motion analysis device and force plate.</prim_outcome>
      <prim_outcome>The angle of knee. Timepoint: In pre- and post-test. Method of measurement: Motion analysis device and force plate.</prim_outcome>
      <prim_outcome>The angle of hip. Timepoint: In pre- and post-test. Method of measurement: Motion analysis device and force plate.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Shahid Beheshti University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2022-05-21</approval_date>
        <contact_name>Ethical Committee of Research Institute of Physical Education and Sports Sciences</contact_name>
        <contact_address>No.3, Fifth Ave, Miremad St, Ostad Motahati St, Tehran Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
